FR2845000B1 - Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute - Google Patents

Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute

Info

Publication number
FR2845000B1
FR2845000B1 FR0212018A FR0212018A FR2845000B1 FR 2845000 B1 FR2845000 B1 FR 2845000B1 FR 0212018 A FR0212018 A FR 0212018A FR 0212018 A FR0212018 A FR 0212018A FR 2845000 B1 FR2845000 B1 FR 2845000B1
Authority
FR
France
Prior art keywords
stimulating
inducing
braking
hair
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0212018A
Other languages
English (en)
Other versions
FR2845000A1 (fr
Inventor
Christophe Boulle
Roger Rozot
Maria Dalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0212018A priority Critical patent/FR2845000B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to CA002499689A priority patent/CA2499689A1/fr
Priority to MXPA05003126A priority patent/MXPA05003126A/es
Priority to PCT/FR2003/002823 priority patent/WO2004028441A2/fr
Priority to RU2005112734/15A priority patent/RU2316325C2/ru
Priority to KR1020057005150A priority patent/KR20050067397A/ko
Priority to CNA038254522A priority patent/CN1703259A/zh
Priority to BR0314490-9A priority patent/BR0314490A/pt
Priority to JP2005501926A priority patent/JP2006518338A/ja
Priority to EP03798227A priority patent/EP1545708A2/fr
Priority to AU2003299068A priority patent/AU2003299068B2/en
Priority to US10/671,508 priority patent/US7294641B2/en
Publication of FR2845000A1 publication Critical patent/FR2845000A1/fr
Application granted granted Critical
Publication of FR2845000B1 publication Critical patent/FR2845000B1/fr
Priority to US11/902,864 priority patent/US20080076809A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
FR0212018A 2002-09-27 2002-09-27 Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute Expired - Fee Related FR2845000B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0212018A FR2845000B1 (fr) 2002-09-27 2002-09-27 Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
AU2003299068A AU2003299068B2 (en) 2002-09-27 2003-09-25 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof
PCT/FR2003/002823 WO2004028441A2 (fr) 2002-09-27 2003-09-25 Compose heterocyclique pour stimuler ou induire la pousse des cheveux ou des cils et/ou freiner leur chute, composition le contenant, ses utilisations
RU2005112734/15A RU2316325C2 (ru) 2002-09-27 2003-09-25 Гетероциклическое соединение, стимулирующее или вызывающее рост волос или ресниц и/или препятствующее их выпадению, композиция, содержащая соединение, ее применение
KR1020057005150A KR20050067397A (ko) 2002-09-27 2003-09-25 모발 또는 속눈썹 성장을 자극 또는 유도 및/또는 모발손실을 감속하는 헤테로사이클릭 화합물, 이를 함유하는조성물 및 그의 용도
CNA038254522A CN1703259A (zh) 2002-09-27 2003-09-25 刺激或诱导头发或睫毛的生长和/或减慢它们的脱失的杂环化合物,和包括该化合物的组合物及其用途
CA002499689A CA2499689A1 (fr) 2002-09-27 2003-09-25 Compose heterocyclique pour stimuler ou induire la pousse des cheveux ou des cils et/ou freiner leur chute, composition le contenant, ses utilisations
JP2005501926A JP2006518338A (ja) 2002-09-27 2003-09-25 毛髪又は睫毛の成長を刺激又は誘発させ、及び／又は抜毛を遅延化するための複素環化合物、及びそれを含有する組成物、及びその用途
EP03798227A EP1545708A2 (fr) 2002-09-27 2003-09-25 Compose heterocyclique pour stimuler ou induire la pousse des cheveux ou des cils et/ou freiner leur chute, composition le contenant, ses utilisations
MXPA05003126A MXPA05003126A (es) 2002-09-27 2003-09-25 Compuesto heterociclico para estimular o inducir el crecimiento del cabello o pestanas y/o frenar la perdida de cabello, c0mposicion que contiene el mismo y usos del mismo.
BR0314490-9A BR0314490A (pt) 2002-09-27 2003-09-25 Usos de pelo menos um composto heterocìclico, composições de cuidado ou de maquilagem das fibras queratìnicas, processo de tratamento cosmético das fibras queratìnicas, processo de cuidado cosmético e/ou de maquilagem dos cìlios humanos, processo de cuidado cosmético dos cabelos e/ou do couro cabeludo humanos e compostos heterocìclicos
US10/671,508 US7294641B2 (en) 2002-09-27 2003-09-29 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses
US11/902,864 US20080076809A1 (en) 2002-09-27 2007-09-26 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212018A FR2845000B1 (fr) 2002-09-27 2002-09-27 Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute

Publications (2)

Publication Number Publication Date
FR2845000A1 FR2845000A1 (fr) 2004-04-02
FR2845000B1 true FR2845000B1 (fr) 2005-05-27

Family

ID=31985302

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0212018A Expired - Fee Related FR2845000B1 (fr) 2002-09-27 2002-09-27 Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute

Country Status (12)

Country Link
US (2) US7294641B2 (fr)
EP (1) EP1545708A2 (fr)
JP (1) JP2006518338A (fr)
KR (1) KR20050067397A (fr)
CN (1) CN1703259A (fr)
AU (1) AU2003299068B2 (fr)
BR (1) BR0314490A (fr)
CA (1) CA2499689A1 (fr)
FR (1) FR2845000B1 (fr)
MX (1) MXPA05003126A (fr)
RU (1) RU2316325C2 (fr)
WO (1) WO2004028441A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073594A2 (fr) * 2003-02-12 2004-09-02 L'oreal Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
FR2887444A1 (fr) * 2005-06-28 2006-12-29 Oreal Composes benzylidene-1,3-thiazolidine-2,4-diones, leurs utilisations et compositions pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute et/ou augmenter leur densite.
US20070078175A1 (en) * 2005-10-05 2007-04-05 L'oreal Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof
FR2891543A1 (fr) * 2005-10-05 2007-04-06 Oreal Composes phenyl-furyl-methyl-thiazolidine-2,4-diones ou phenyl-thienyl-methyl-thiazolidine-2,4-diones ; utilisations pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute ; compositions le contenant
US20080059313A1 (en) * 2006-08-30 2008-03-06 Oblong John E Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
WO2009107072A1 (fr) * 2008-02-29 2009-09-03 The Procter & Gamble Company Compositions de traitement capillaire et procédés d'augmentation du diamètre des cheveux
US20080275118A1 (en) * 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
DE102009044974A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Dihydroquercetin und mindestens einer Aminosäure zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses
EP2515903A4 (fr) * 2009-12-23 2013-07-10 Peter Maccallum Cancer Inst Composés, leurs préparations et leurs utilisations
EP2519653A4 (fr) * 2009-12-31 2013-07-10 Univ Columbia Procédés pour la détection et la régulation de l'alopécie en aires, et de cohortes de gènes de celle-ci
WO2011130419A2 (fr) 2010-04-13 2011-10-20 The Regents Of The University Of California Agents antiviraux et antiparasitaires à large spectre
WO2015065716A1 (fr) 2013-10-15 2015-05-07 Case Western Reserve University Compositions et procédés de modulation de l'activité de la déshydrogénase à chaîne courte
EP2996775A1 (fr) 2013-05-16 2016-03-23 The Procter & Gamble Company Composition d'épaississement de cheveux et procédés d'utilisation
CN104306168B (zh) * 2014-10-15 2017-05-24 华东师范大学 氮‑(4‑氯‑2,5‑二甲氧基苯基)‑5‑异丙基‑2‑甲氧基苯磺酰胺在促进毛发生长的应用
CN107921025A (zh) 2015-03-08 2018-04-17 卡斯西部储备大学 用于治疗纤维症的短链脱氢酶活性的抑制剂
EP3548035A4 (fr) 2016-11-30 2020-07-22 Case Western Reserve University Combinaisons d'inhibiteurs de 15-pgdh avec des corcostéroïdes et/ou des inhibiteurs du tnf et leurs utilisations
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
MA55147A (fr) 2018-11-21 2021-09-29 Univ Texas Compositions et procédés de modulation de l'activité de la déshydrogénase à chaîne courte

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE4027038A1 (de) * 1990-08-27 1992-03-05 Wella Ag 3-amino-5-benzyliden-2-thioxo-thiazolidin-4- one, verfahren zu deren herstellung und diese enthaltendes kosmetisches mittel
JPH09249669A (ja) * 1996-03-13 1997-09-22 Ono Pharmaceut Co Ltd 縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
AU7684798A (en) * 1997-05-30 1998-12-30 Texas Biotechnology Corporation Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
JPH11302280A (ja) * 1998-04-17 1999-11-02 Ono Pharmaceut Co Ltd チアゾリジン誘導体、およびその誘導体を有効成分とする医薬
KR20010099623A (ko) * 1998-08-21 2001-11-09 비로파마 인코포레이티드 바이러스 감염 및 관련 질병을 치료 또는 예방하는화합물, 조성물 및 방법
AU3111700A (en) * 1998-12-04 2000-06-19 Structural Bioinformatics Inc. Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity
AU3982601A (en) * 2000-02-23 2001-09-03 Orentreich Foundation For The Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
AU2001296961A1 (en) * 2000-09-29 2002-04-08 Bayer Pharmaceuticals Corporation 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
US20050042674A9 (en) * 2002-02-21 2005-02-24 Lin Yu Common ligand mimics: thiazolidinediones and rhodanines
WO2004073594A2 (fr) * 2003-02-12 2004-09-02 L'oreal Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres

Also Published As

Publication number Publication date
AU2003299068A1 (en) 2004-04-19
WO2004028441A8 (fr) 2007-01-18
US7294641B2 (en) 2007-11-13
WO2004028441A3 (fr) 2004-05-06
JP2006518338A (ja) 2006-08-10
EP1545708A2 (fr) 2005-06-29
US20060008436A1 (en) 2006-01-12
FR2845000A1 (fr) 2004-04-02
CN1703259A (zh) 2005-11-30
AU2003299068B2 (en) 2008-06-05
US20080076809A1 (en) 2008-03-27
KR20050067397A (ko) 2005-07-01
CA2499689A1 (fr) 2004-04-08
WO2004028441A2 (fr) 2004-04-08
MXPA05003126A (es) 2006-03-09
RU2005112734A (ru) 2006-02-27
RU2316325C2 (ru) 2008-02-10
BR0314490A (pt) 2005-08-02

Similar Documents

Publication Publication Date Title
FR2845000B1 (fr) Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
AU2003223579A8 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
IL160550A0 (en) Plaster for the treatment of dysfunctions and disorders of nail growth
ATE253361T1 (de) Mittel zur gesteuerten freisetzung von paroxetin
FR2846545B1 (fr) Implant d'osteosynthese intramedullaire
GB2319725B (en) Extracting particles produced by the treating of human or animal nails
FR2794019B1 (fr) Implant d'osteosynthese
PL356769A1 (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
FR2778558B1 (fr) Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
DE29811670U1 (de) Vorrichtung zur Versorgung von Knochenbrüchen
MY134059A (en) Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
FR2777291B1 (fr) Nouvelle metalloprotease membranaire nep ii et son utilisation pour le criblage d'inhibiteurs utiles en therapie
FR2823109B1 (fr) Utilisation de l'alverine ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2858216B1 (fr) Composition contenant un 2-thioacetamide, son utilisation pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
FR2794967B1 (fr) Ogive dilatatrice introduite entre des surfaces osseuses articulaires concaves pour en restaurer l'ecartement et la position angulaire
FR2836635B1 (fr) Systeme d'assurage pour la pratique de l'escalade et de l'alpinisme
EE200200348A (et) Ravimkoostis kasutamiseks valu ravis
FR2846230B1 (fr) Composition capillaire contenant un compose tetrazolique, son utilisation pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
FR2846232B1 (fr) Composition capillaire contenant un compose styryl-pyrazole, son utilisation pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
FR2850105B1 (fr) Moyens pour la regulation de l'expression des isoformes humaines de l'ant
DE29717031U1 (de) Vorrichtung zur Pflege des menschlichen Körpers
ITMI992320A0 (it) Apparecchiatura per l'inoculazione di medicamenti in animali
IT244062Y1 (it) Dispositivo odontoiatrico per comparare e determinare l'aspettocromatico di protesi dentali
ITTO20030467A1 (it) Procedimento e dispositivo per l'eiezione di micro-gocce
DE29819571U1 (de) Vorrichtung zur Pflege des menschlichen Körpers

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090529